10.20 (-%)
As of Dec 11, 2024
Source:
Kura Oncology, Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our pipeline consists of small molecule product candidates that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes, and we intend to pair them with molecular or cellular diagnostics to identify those patients most likely to respond to treatment.
Country | United States |
Headquarters | san diego, california |
Phone Number | (858) 500-8800 |
Industry | manufacturing |
CEO | Troy E. Wilson |
Website | www.kuraoncology.com |